Market News

Compugen Ltd. (CGEN) At $6.12 Forms Top; MEDTAINER (MDTR) Shorts Lowered By 92.53%

Compugen Ltd. (CGEN) At $6.12 Forms Top; MEDTAINER (MDTR) Shorts Lowered By 92.53%

MEDTAINER INC (OTCMKTS:MDTR) had a decrease of 92.53% in short interest. MDTR’s SI was 3,100 shares in January as released by FINRA. Its down 92.53% from 41,500 shares previously. It closed at $0.2001 lastly. It is down 0.00% since January 21, 2019 and is . It has by 0.00% the […]

Reviewing Halozyme Therapeutics Inc. (HALO)’s and Mersana Therapeutics Inc. (NASDAQ:MRSN)’s results

We are contrasting Halozyme Therapeutics Inc. (NASDAQ:HALO) and Mersana Therapeutics Inc. (NASDAQ:MRSN) on their analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Halozyme Therapeutics Inc. 19 […]

Ims Capital Management Increased Intel (INTC) Holding By $509,847; Medtronic PLC. Ordinary Shares (MDT) Shorts Down By 16.59%

Ims Capital Management Increased Intel (INTC) Holding By $509,847; Medtronic PLC. Ordinary Shares (MDT) Shorts Down By 16.59%

Ims Capital Management increased Intel Corp (INTC) stake by 26.9% reported in 2019Q3 SEC filing. Ims Capital Management acquired 9,997 shares as Intel Corp (INTC)’s stock rose 10.12%. The Ims Capital Management holds 47,165 shares with $2.43 million value, up from 37,168 last quarter. Intel Corp now has $259.26B valuation. […]

Prospect Capital NT 061524 (PBB) At $25.63 Forms Top; Coldstream Capital Management Has Lowered By $429,984 Its Costco Whsl New (COST) Stake

Prospect Capital NT 061524 (PBB) At $25.63 Forms Top; Coldstream Capital Management Has Lowered By $429,984 Its Costco Whsl New (COST) Stake

Coldstream Capital Management Inc decreased Costco Whsl Corp New (COST) stake by 4.32% reported in 2019Q3 SEC filing. Coldstream Capital Management Inc sold 1,493 shares as Costco Whsl Corp New (COST)’s stock declined 1.36%. The Coldstream Capital Management Inc holds 33,047 shares with $9.52M value, down from 34,540 last quarter. […]

Duff & Phelps Select MLP and Midstream Energy Fund (DSE) and Credit Suisse High Yield Bond Fund Inc. (NYSE:DHY) Comparison side by side

Duff & Phelps Select MLP and Midstream Energy Fund (NYSE:DSE) and Credit Suisse High Yield Bond Fund Inc. (NYSE:DHY) have been rivals in the Asset Management for quite some time. Below is a review of each business including various aspects such as risk, analyst recommendations, profitability, dividends, earnings and valuation, […]

NBT Bancorp Inc. (NBTB) Analysts See $0.63 EPS; Canyon Capital Advisors Has Increased Ypf Sociedad Anonima (YPF) Position By $19.29 Million

NBT Bancorp Inc. (NBTB) Analysts See $0.63 EPS; Canyon Capital Advisors Has Increased Ypf Sociedad Anonima (YPF) Position By $19.29 Million

Analysts expect NBT Bancorp Inc. (NASDAQ:NBTB) to report $0.63 EPS on January, 27.They anticipate $0.02 EPS change or 3.08% from last quarter’s $0.65 EPS. NBTB’s profit would be $27.59M giving it 16.24 P/E if the $0.63 EPS is correct. After having $0.73 EPS previously, NBT Bancorp Inc.’s analysts see -13.70% […]

EPS for Mid Penn Bancorp, Inc. (MPB) Expected At $0.57; MONADELPHOUS GROUP ORDINARY SHARES AUST (MDPHF) Sellers Increased By 22.2% Their Shorts

EPS for Mid Penn Bancorp, Inc. (MPB) Expected At $0.57; MONADELPHOUS GROUP ORDINARY SHARES AUST (MDPHF) Sellers Increased By 22.2% Their Shorts

MONADELPHOUS GROUP ORDINARY SHARES AUST (OTCMKTS:MDPHF) had an increase of 22.2% in short interest. MDPHF’s SI was 51,200 shares in January as released by FINRA. Its up 22.2% from 41,900 shares previously. With 100 avg volume, 512 days are for MONADELPHOUS GROUP ORDINARY SHARES AUST (OTCMKTS:MDPHF)’s short sellers to cover […]

Therapix Biosciences Ltd. (TRPX) and Avid Bioservices Inc. (NASDAQ:CDMO) Contrasting side by side

This is a contrast between Therapix Biosciences Ltd. (NASDAQ:TRPX) and Avid Bioservices Inc. (NASDAQ:CDMO) based on their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]